Actively Recruiting
Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
Led by El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez · Updated on 2024-05-31
150
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine the efficacy in seizure reduction when comparing orodispersable clonazepam versus usual treatment (i.e. medication load, intravenous high- dose benzodiazepines) of seizure clusters in a third level center of care in Mexico city.
CONDITIONS
Official Title
Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least age of 18
- Patient available for follow-up
- Previous diagnosis of epilepsy
- Patient meets criteria for seizure clusters (3 or more seizures in a period of 24 hours)
You will not qualify if you...
- Risk factors for epilepsy have been identified and uncontrolled
- Younger than 18 years old
- Follow-up in another healthcare unit
- No previous epilepsy diagnosis
- Adequate control of epilepsy
- Patient meets criteria for clinical or electrographic status epilepticus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Neurología y Neurocirugía "Dr. Manuel Velasco Suárez"
Mexico City, Mexico City, Mexico, 14269
Actively Recruiting
Research Team
E
Elma M Paredes-Aragón, MD
CONTACT
J
Juan C Lopez Hernandez, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here